【摘要】 目的观察耻骨后药物注射治疗慢性前列腺炎的疗效。方法回顾性总结根据美国国立卫生研究院(NIH)标准诊断为Ⅱ型及Ⅲ型经口服药物治疗效果欠佳的慢性前列腺炎患者300例,年龄15~64岁,美国国立卫生研究院慢性前列腺炎症状评分(NIH-CPSI)>19分,用庆大霉素8万U、地塞米松5mg、1%利多卡因2ml注射至耻骨后间隙前列腺外周,每2~3天1次,共6~9次,采用NIH-CPSI的改变判定疗效。结果观察4~8周,治愈108例(36%),显效135例(45%),有效30例(10%),无效27例(9%),总有效率91%。2例出现排尿轻微疼痛,持续1d,未经治疗而自行消失。结论耻骨后药物注射治疗慢性前列腺炎方便、安全、有效。更多还原

【Abstract】 Objective To observe the curative effects on the treatment of 300 cases of chronic prostatitis by using retropubic pharmaceutics injection.Methods 300 patients of our department diagnosed as type Ⅱ and type Ⅲ chronic prostatitis according to NIH standardization were retrospectively studied between April 2002 and March 2006.All these patients had poor improvement with oral medication.Their age ranged from 15 to 64 years old and their scores evaluated by NIH-CPSI(NIH classification system for prostatitis) were lower than 19.Eighty thousand units of gentamycin,5mg of dexamethasone,and 2ml of lidocaine with one percent concentration were injected together to the periphery of prostatae 2 to 3 times a day,6 to 9 times in total.The curative effect were evaluated by using the changes of NIH-CPSI.Results After 4 to 8 week’s observation,108 cases were cured(22.5%),135 cases had an evidently effect(37.5%),30 cases had a helpful effect(27.5%),27 cases had no effect.The total efficiency was 91%.2 cases had a little pain during urination and the symptom disappeared after one day without any treatment.Conclusion Retropubic pharmaceutics injection is a convenient,safe,and effective treatment on patients with chronic prostatitis.更多还原